Filter By Industry
Filter By Tag

Newsroom

Stemedica International SA Press releases

1 - 8 of 8 Press Releases

Stemedica International Discovers Connection between Gut Microbiome and Alzheimer's Disease (AD)
Feb 28, 2017
Peer-reviewed Research Published in Nature's "Scientific Reports"

Stemedica International, SA Wins "Favorit" Entrepreneurship 2016 Award in Switzerland
Dec 19, 2016
Alexei Lukashev, PhD, General Manager, Awarded First Place in Russian Speaking Entrepreneur of the Year Competition

Clinical Trials for Alzheimer's Disease (CTAD) Selects Stemedica International to Present
Nov 21, 2016
Latest preclinical and clinical data regarding the effects of Stemedica's proprietary stem cells on Alzheimer's disease to be presented and discussed

University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica's Stem Cells for Alzheimer's disease
Nov 01, 2016
The Only Alzheimer's Disease Clinical Trial Using Stemedica's Ischemia-Tolerant Mesenchymal Stem Cells (itMSCs) Continues Recruitment at UCI

Society for Neuroscience (SfN) Selects Stemedica International's Research as a Hot Topic
Oct 26, 2016
Latest preclinical data regarding the effects of Stemedica's proprietary stem cells on Alzheimer's disease to be publicized

Stemedica International to Present at Geneva Springfield Alzheimer’s Conference in Athens, Greece
Mar 10, 2016
Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s Disease announced today that its Chief Scientist, Tristan Bolmont, PhD, will present at the upcoming 14th International Athens /...

Stemedica International Receives Approval from Emory University to Initiate Alzheimer’s Disease Study with Adult Allogeneic Stem Cells
Feb 24, 2016
Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s Disease announced today that it has received IRB approval from Emory University in Atlanta, Georgia to initiate a clinical study entitled,...

Stemedica International and EPFL Awarded Swiss Government Grant for Diabetes and Stem Cell Research
Aug 26, 2015
Stemedica International, a subsidiary of Stemedica Cell Technologies, Inc.


Stemedica International SA RSS Feed